Search | TVST | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina November 2024

Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema

PDF

Cheikh Diack; Robert L. Avery; Chui Ming Gemmy Cheung; Karl G. Csaky; Leonid Gibiansky; Felix Jaminion; Ekaterina Gibiansky; Denise Sickert; Ivo Stoilov; Valerie Cosson; Katrijn Bogman
TAGS: diabetic macular edema, exudative age-related macular degeneration, faricimab, hypertension, vascular endothelial growth factor a, pharmacodynamics
Trans. Vis. Sci. Tech.. 2024; 13(11):13. https://doi.org/10.1167/tvst.13.11.13

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

Key clinical and anatomic outcomes from the YOSEMITE/RHINE trials of faricimab in patients with DME.

Niranjan Manoharan; Manuel Amador; Jeffrey Willis; Francis Abreu; Ivo Stoilov; Florie Mar; Kara Gibson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6239.

ARVO Annual Meeting Abstract June 2024

Elevatum study design and rationale: a phase 4 trial of faricimab (VABYSMO) in underrepresented patients with DME

Jeremiah Brown; Matthew Cunningham; Joseph M Coney; Adrienne Scott; Manuel Amador; Jennifer Chang; Ming Yang; Ivo Stoilov; Luis Gonzalez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6242.

ARVO Annual Meeting Abstract June 2024

Clinical pearls from the TENAYA/LUCERNE trials of faricimab in patients with nAMD

Sara Haug; Manuel Amador; Aachal Kotecha; Philippe Margaron; Ivo Stoilov; Yannan Tang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5696.

ARVO Annual Meeting Abstract June 2023

Faricimab causes rapid and sustained intraocular suppression of Ang-2 and VEGF-A for up to 16 weeks in nAMD and DME

KATRIJN BOGMAN; Robert Avery; Ivo Stoilov; Cheikh Diack

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2633.

ARVO Annual Meeting Abstract June 2020

Clinical Effects of Blocking Ang-2 and VEGF with Faricimab in the Phase 2 STAIRWAY Trial

Carl J Danzig; Hugh Lin; Pascal Guibord; David Silverman; Carlos Quezada Ruiz; Ivo Stoilov; Zdenka Haskova

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1160.

ARVO Annual Meeting Abstract June 2020

Anti-VEGF Resistant Subretinal Fluid is Associated With Reduced Risk of Macular Atrophy and Better Visual Acuity: Drug-Induced Choroidal New Vessel Homeostasis?

Marco A Zarbin; Ivo Stoilov; Lauren Hill

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3503.

ARVO Annual Meeting Abstract June 2020

Baseline diabetic retinopathy severity affects time to clinically meaningful improvements in diabetic retinopathy during ranibizumab treatment

Mitchell Goff; Lauren Hill; Karen Colbert; Ivo Stoilov; David Faber

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4035.

ARVO Annual Meeting Abstract June 2020

Comparative efficacy of anti-vascular endothelial growth factor (VEGF) treatment regimens for neovascular age-related macular degeneration (nAMD): A network meta-analysis

Vincent Garmo; Ivo Stoilov; Caroline Solon; Ferhina S Ali; Jennifer Uyei; Pinar Bilir; Andreas Karabis; Rajpal Singh; Yilin Jiang; Diana V Do

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4228.

ARVO Annual Meeting Abstract July 2019

Regression of diabetic retinopathy with anti-VEGF treatment: what is learned from a meta-analysis of four pivotal clinical trials

Diana V Do; Quan Dong Nguyen; Bann-Mo Day; Tatiana Ecoiffier; Ivo Stoilov

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1732.

ARVO Annual Meeting Abstract July 2019

Visual impairment in patients with giant cell arteritis treated with tocilizumab in real-world clinical practice

Ivo Stoilov; Timothy J. McCulley; Jinglan Pei; Paris N. Sidiropoulos; Christine Birchwood; Jennie Best; John H. Stone; Sebastian Unizony

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):242.

ARVO Annual Meeting Abstract September 2016

Long-term diabetic retinopathy and macular edema outcomes with anti-VEGF treatments in randomized controlled clinical studies

Marco A Zarbin; Ivo Stoilov; Na Lu

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2083.

ARVO Annual Meeting Abstract April 2014

Low Luminance Visual Acuity and Treatment Response in Patients with wet Age-Related Macular Degeneration Enrolled in the HARBOR Study

Ronald E P Frenkel; Howard Shapiro; Ivo Stoilov

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3963.

Advertisement